Andrea Ellis, a director at $BBIO, sold 10,000 shares of the company on 04-14-2025 for an estimated $350,000. We received data on the trade from a recent SEC filing ...

H.C. Wainwright analyst Raghuram Selvaraju raised the firm’s price target on BridgeBio (BBIO) to $53 from $49 and keeps a Buy rating on the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

At close: April 17 at 4:00:02 PM EDT ...

Escolha uma ou mais carteiras para adicionar o ativo. Se preferir, crie uma nova carteira.

This stock can be held in an Investment ISA and an Investment Account ...

Highlight,Sector Focus,: BridgeBio Pharma operates in the biopharmaceutical sector, with a focus on genetic conditions and oncology.,Insider Actions,: Notable insider share transactions have been ...